Pictured (left to right): Warren Baker, Director, University-Schools Program; Pam Carroll, Asst. Director, University-Schools Program; Zoe Locklear, Dean, School of Education; Bill Shore, Director, Community Relations with GlaxoSmithKline; and Darrell Johnson, Chair, UNCP Foundation.
Research-based pharmaceutical company GlaxoSmithKline and UNC Pembroke's School of Education have teamed up to award $20,000 in grants to 21 classroom teachers in the region.
Bill Shore, GlaxoSmithKline's director of community relations, announced that the company would renew its commitment to the program for a second year. He made the announcement this week at an awards dinner held at the university to honor the grant recipients.
Winning research projects came from elementary and middle schools from Acme-Delco to Fort Bragg and had titles like:
- "What Color am I: Using the Spectrum Temperament Development Model in the Middle School,"
- 'Connecting Phonics and Phonemic Awareness in Emerging Readers,"
- "Math Club: Home-School Lending Library,"
- "Birds and Butterflies: A Secret Garden for Readers,"
- "Water: An Important Natural Resource" and
- "Science Projects Integrated Through Children's Literature."
"It's a privilege to be in a roomful of heroes," Mr. Shore said. "For us at GlaxoSmithKline, this is a great opportunity to help teachers."
GlaxoSmithKline's partnership with Pembroke originated when Mr. Shore met UNCP's Education Dean Zoe Locklear at a meeting of Gov. Mike Easley's First in America Task Force.
"Bill's company is interested in supporting diversity, and I assured him that this is the most diverse region in North Carolina," Dr. Locklear said. "GlaxoSmithKline is a corporate leader in caring about the public schools of North Carolina."
Chancellor Allen C. Meadors said there is a crisis in moral support for U.S. public schools, and private sector support like GlaxoSmithKline project is important.
"Grants like this one help our teachers do more for their children," Chancellor Meadors said. "These projects are critical."
GlaxoSmithKline is one of the world's leading research-based pharmaceutical and healthcare companies with North American operations based in the Research Triangle Park, N.C. and Philadelphia.
The company's philosophy is to target support on selected programs that are innovative, sustainable and which produce tangible results.